Entero Therapeutics Total Revenue

The latest total revenue for ENTO is $74K as of March 2026. In the prior-year period, the figure was $0. That is below the sector sector average of $1.1B. Investors often review this figure alongside Entero Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ENTO's total revenue moved from $0 to $74K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Entero Therapeutics's operating scale or balance-sheet position.

Against its sector companies, ENTO currently prints $74K for total revenue, while the sector average sits near $1.1B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Entero Therapeutics's growth, margins, and balance sheet.

A total revenue figure of $74K for ENTO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.1B. Explore the charts below for those layers of context.

After noting ENTO's total revenue ($74K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.